131 related articles for article (PubMed ID: 37608127)
1. Removal rate of 5-fluorouracil and its metabolites in patients on hemodialysis: a report of two cases of colorectal cancer patients with end-stage renal failure.
Imamaki H; Oura M; Oguro F; Nishikawa Y; Nakagawa S; Funakoshi T; Kataoka S; Horimatsu T; Yonezawa A; Matsubara T; Watanabe N; Muto M; Yanagita M; Ozaki Y
Cancer Chemother Pharmacol; 2024 Feb; 93(2):161-167. PubMed ID: 37608127
[TBL] [Abstract][Full Text] [Related]
2. Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Ozaki Y; Imamaki H; Ikeda A; Oura M; Nakagawa S; Funakoshi T; Kataoka S; Nishikawa Y; Horimatsu T; Yonezawa A; Matsubara T; Yanagita M; Muto M; Watanabe N
Cancer Chemother Pharmacol; 2020 Nov; 86(5):693-699. PubMed ID: 33011861
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
[TBL] [Abstract][Full Text] [Related]
4. Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil.
Thiberville L; Compagnon P; Moore N; Bastian G; Richard MO; Hellot MF; Vincent C; Kannass MM; Dominique S; Thuillez C
Cancer Chemother Pharmacol; 1994; 35(1):64-70. PubMed ID: 7987979
[TBL] [Abstract][Full Text] [Related]
5. Plasma level of a 5-fluorouracil metabolite, fluoro-beta-alanine correlates with dihydropyrimidine dehydrogenase activity of peripheral blood mononuclear cells in 5-fluorouracil treated patients.
Furuhata T; Kawakami M; Okita K; Kimura Y; Kihara C; Tsuruma T; Ohmura T; Yamaguchi K; Hata F; Katsuramaki T; Sasaki K; Hirata K
J Exp Clin Cancer Res; 2006 Mar; 25(1):79-82. PubMed ID: 16761622
[TBL] [Abstract][Full Text] [Related]
6. Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
Knikman JE; de Vries N; Rosing H; Cats A; Guchelaar HJ; Beijnen JH
Pharmazie; 2023 Aug; 78(8):107-112. PubMed ID: 37592424
[TBL] [Abstract][Full Text] [Related]
7. Systemic absorption of 5-fluorouracil during vitrectomy.
Creten O; Spileers W; Stalmans P
Am J Ophthalmol; 2006 Jul; 142(1):194-6. PubMed ID: 16815286
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis.
Rengelshausen J; Hull WE; Schwenger V; Göggelmann C; Walter-Sack I; Bommer J
Am J Kidney Dis; 2002 Feb; 39(2):E10. PubMed ID: 11840401
[TBL] [Abstract][Full Text] [Related]
9. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
Sweeny DJ; Barnes S; Diasio RB
Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
[TBL] [Abstract][Full Text] [Related]
10. Systemic resorption of 5-fluorouracil used in infusion fluid during vitrectomy.
Creten O; Spileers W; Stalmans P
Bull Soc Belge Ophtalmol; 2007; (303):37-41. PubMed ID: 17894285
[TBL] [Abstract][Full Text] [Related]
11. Correlation between pharmacokinetic parameters of 5-fluorouracil and related metabolites and adverse reactions in East-Asian patients with advanced colorectal cancer.
Tong Z; Cheng M; Yu Y; Yu J; Yin Y; Liu J; Zhang S; Jiang S; Dong M
Cancer Chemother Pharmacol; 2022 Mar; 89(3):323-330. PubMed ID: 35067736
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients.
Gieschke R; Burger HU; Reigner B; Blesch KS; Steimer JL
Br J Clin Pharmacol; 2003 Mar; 55(3):252-63. PubMed ID: 12630975
[TBL] [Abstract][Full Text] [Related]
13. alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracil.
Cao S; Baccanari DP; Rustum YM; Davis ST; Tansik RL; Porter DJ; Spector T
Biochem Pharmacol; 2000 Apr; 59(8):953-60. PubMed ID: 10692560
[TBL] [Abstract][Full Text] [Related]
14. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs.
Yamashita K; Yada H; Ariyoshi T
J Toxicol Sci; 2004 May; 29(2):155-66. PubMed ID: 15206584
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F; Bartolucci R; Calabresi F; Sofra M; Marzola M; Belsanti V; Boni C; Bacchi M
Ann Oncol; 1992 May; 3(5):371-6. PubMed ID: 1616890
[TBL] [Abstract][Full Text] [Related]
17. Safety of a Novel Dialyzer Containing a Fluorinated Polyurethane Surface-Modifying Macromolecule in Patients with End-Stage Kidney Disease.
Meyer JM; Steer D; Weber LA; Zeitone AA; Thakuria M; Ho CH; Aslam S; Mullon C; Kossmann RJ
Blood Purif; 2021; 50(6):959-967. PubMed ID: 33789265
[TBL] [Abstract][Full Text] [Related]
18. Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture.
Akiba T; Okeda R; Tajima T
Acta Neuropathol; 1996 Jul; 92(1):8-13. PubMed ID: 8811119
[TBL] [Abstract][Full Text] [Related]
19. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
[TBL] [Abstract][Full Text] [Related]
20. Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.
Peters GJ; Lankelma J; Kok RM; Noordhuis P; van Groeningen CJ; van der Wilt CL; Meyer S; Pinedo HM
Cancer Chemother Pharmacol; 1993; 31(4):269-76. PubMed ID: 8422689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]